Experimental cancer drug trial halted after early testing
NCT ID NCT06289894
Summary
This early-stage study tested a new drug called BRY805 in adults with advanced solid tumors that hadn't responded to standard treatments. The main goal was to check the drug's safety, find the right dose, and see if it showed any signs of fighting cancer. The trial was terminated early and only enrolled 13 participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Shandong Tumor hospital
Jinan, Shandong, 250117, China
Conditions
Explore the condition pages connected to this study.